Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04159740 · ClinicalTrials.gov registry record

Microbiome and Immunologic Analysis - Women With Endometriosis

A clinical trial of Endometriosis, sponsored by Mayo Clinic.

Completed
Registry status
48
Enrollment target
1
Study location

NCT04159740 is a study of Endometriosis that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04159740, a study of Endometriosis, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
48 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this study is to assess differences in the microbiome between women with and without endometriosis. A second goal of this study is to assess immunologic differences between the eutopic (within the uterus) and ectopic (outside of the uterus) endometrial tissue in women with endometriosis. In order to investigate these areas of interest, 25 women with endometriosis and 25 women without endometriosis will be enrolled. All women will be undergoing a previously scheduled surgical procedure at which time presence or absence of endometriosis will be confirmed and specimens will be obtained.

Conditions Studied

Interventions

  • OTHER Tissue and blood collection

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2020-02-06
Est. Completion 2022-03-11

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04159740

The ClinicalTrials.gov registry entry for NCT04159740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (82% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which Tissue and blood collection is the first listed.

NCT04159740 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04159740 about?

NCT04159740 is a clinical study titled "Microbiome and Immunologic Analysis - Women With Endometriosis". The primary goal of this study is to assess differences in the microbiome between women with and without endometriosis. A second goal of this study is to assess immunologic differences between the eutopic (within the uterus) and ectopic (outside of the uterus) endometrial tissue in women with endom...

What is the current status of trial NCT04159740?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2020-02-06. Estimated completion is 2022-03-11.

What conditions does trial NCT04159740 study?

This clinical trial studies the following conditions: Endometriosis.

What interventions are being tested in trial NCT04159740?

The interventions under investigation include: Tissue and blood collection (OTHER).

Who is sponsoring clinical trial NCT04159740?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04159740 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.